The read at a glance
Computed from the FY2024 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -97.78 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M 5.04 — flag raised, worth a closer lookWatch
Latest filings
- 6-K · Company announcement (foreign filer)2026-08-26
- 6-K · Company announcement (foreign filer)2026-07-08
- 6-K · Company announcement (foreign filer)2026-06-30
- 6-K · Company announcement (foreign filer)2026-06-25
- 6-K · Company announcement (foreign filer)2026-06-05
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Addex Therapeutics Ltd., every answer cited to the official filings🔒
- The Intelligence Brief — added when Addex Therapeutics Ltd.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.